Everence Capital Management Inc Baxter International Inc Transaction History

Everence Capital Management Inc

$1.59 Billion
Q3 2024

A detailed history of Everence Capital Management Inc transactions in Baxter International Inc stock. As of the latest transaction made, Everence Capital Management Inc holds 36,912 shares of BAX stock, worth $1.08 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

36,912

Previous 15,502 138.11%

Holding current value

$1.08 Million

Previous $626,000 123.96%

% of portfolio

0.09%

Previous 0.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$32.85 - $40.26 $703,318 - $861,966	21,410 Added 138.11%	36,912 $1.4 Million
Q4 2023 Jan 30, 2024	SELL	$31.71 - $38.95 $315,197 - $387,163	-9,940 Reduced 39.07%	15,502 $599,000
Q3 2023 Oct 16, 2023	BUY	$37.32 - $49.29 $308,263 - $407,135	8,260 Added 48.07%	25,442 $960,000
Q4 2020 Feb 01, 2021	BUY	$75.39 - $82.36 $107,430 - $117,363	1,425 Added 9.04%	17,182 $1.38 Million
Q3 2020 Feb 01, 2021	SELL	$78.33 - $90.73 $229,506 - $265,838	-2,930 Reduced 15.68%	15,757 $1.27 Million
Q2 2020 Jul 09, 2020	BUY	$78.66 - $94.14 $313,853 - $375,618	3,990 Added 27.15%	18,687 $1.68 Million
Q4 2019 Jan 28, 2020	BUY	$76.7 - $88.45 $666,906 - $769,072	8,695 Added 144.87%	14,697 $1.23 Million
Q1 2019 May 06, 2019	SELL	$64.48 - $81.31 $479,086 - $604,133	-7,430 Reduced 55.32%	6,002 $488,000
Q4 2017 Feb 02, 2018	SELL	$61.45 - $66.05 $207,701 - $223,249	-3,380 Reduced 20.1%	13,432 $868,000
Q3 2017 Oct 31, 2017	BUY	$59.5 - $64.61 $1 Million - $1.09 Million	16,812	16,812 $1.06 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Account

Everence Capital Management Inc Baxter International Inc Transaction History